Volume 7, Issue 4 pp. 621-628
Original Article
Free Access

Plasma gaba, gaba-like activity and the brain gaba-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy

Jill E. Maddison B.V.Sc.

Corresponding Author

Jill E. Maddison B.V.Sc.

Department of Medicine, Westmead Hospital and Department of Pharmacology, University of Sydney, N.S.W. 2006, Australia

Department of Pharmacology, University of Sydney, N.S.W. 2006, Australia===Search for more papers by this author
Peter R. Dodd

Peter R. Dodd

Department of Medicine, Westmead Hospital and Department of Pharmacology, University of Sydney, N.S.W. 2006, Australia

Search for more papers by this author
Murray Morrison

Murray Morrison

Department of Medicine, Westmead Hospital and Department of Pharmacology, University of Sydney, N.S.W. 2006, Australia

Search for more papers by this author
Graham A. R. Johnston

Graham A. R. Johnston

Department of Medicine, Westmead Hospital and Department of Pharmacology, University of Sydney, N.S.W. 2006, Australia

Search for more papers by this author
Geoffrey C. Farrell

Geoffrey C. Farrell

Department of Medicine, Westmead Hospital and Department of Pharmacology, University of Sydney, N.S.W. 2006, Australia

Search for more papers by this author
First published: July/September 1987
Citations: 74

Abstract

Plasma γ-aminobutyric acid (GABA)-like activity, plasma GABA and the brain GABA-benzodiazepine receptor complex were studied in rats with chronic hepatic encephalopathy. Portal vein ligation (after prior subcutaneous transposition of the spleen) results in complete portal bypass of splanchnic blood. In addition, significant hepatocellular damage was superimposed on this model of portosystemic shunting by ligation of the common bile duct. Plasma GABA-like activity (determined by radioreceptor assay) and true plasma GABA concentrations (determined by high-performance liquid chromatography) were found to be significantly increased in both portal vein-ligated and portal vein and bile duct-ligated rats, compared with controls. However, plasma GABA-like activity was consistently greater than the concentration of true GABA in the plasma of all rats. This suggested the presence of a GABA-like factor in plasma that can inhibit [3H]GABA binding, but is not GABA itself. The concentration of this GABA-like factor was significantly increased in the plasma of rats with chronic hepatic encephalopathy

Despite the significant increase in plasma GABA-like activity and plasma GABA concentrations, there was no alteration in the affinity or density of the physiologically relevant, low-affinity brain GABA binding site in the rats with portal vein ligation, with or without bile duct ligation. There was also no significant alteration in brain benzodiazepine binding in these rats. GABA enhancement of benzodiazepine binding was unchanged in the portal vein-ligated rats. However, the maximal enhancement of benzodiazepine binding was decreased in the rats with portal vein and bile duct ligation.

There appears to be no substantial evidence that brain GABAergic neurotransmission is increased in these models of chronic hepatic encephalopathy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.